• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性低级别胶质瘤的病因发病机制。

The etiopathogenesis of diffuse low-grade gliomas.

机构信息

Department of Medical Oncology, Institut Régional du Cancer de Montpellier (ICM) - Val d'Aurelle, 208 Rue des Apothicaires, 34298 Montpellier, France; Institute for Neuroscience of Montpellier, INSERM U1051, Team "Plasticity of Central Nervous System, Human Stem Cells and Glial Tumors," Saint Eloi Hospital, Montpellier University Medical Center, 34295 Montpellier, France.

Institute for Neuroscience of Montpellier, INSERM U1051, Team "Plasticity of Central Nervous System, Human Stem Cells and Glial Tumors," Saint Eloi Hospital, Montpellier University Medical Center, 34295 Montpellier, France; Tumor and Cell Biology Laboratory, Arnaud de Villeneuve Hospital, 371 Avenue du Doyen Gaston Giraud, Montpellier University Medical Center, 34295 Montpellier, France.

出版信息

Crit Rev Oncol Hematol. 2017 Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Epub 2016 Nov 27.

DOI:10.1016/j.critrevonc.2016.11.014
PMID:28010898
Abstract

The origins of diffuse low-grade gliomas (DLGG) are unknown. Beyond some limited data on their temporal and cellular origins, the mechanisms and risk factors involved are poorly known. First, based on strong relationships between DLGG development and the eloquence of brain regions frequently invaded by these tumors, we propose a "functional theory" to explain the origin of DLGG. Second, the biological pathways involved in DLGG genesis may differ according to tumor location (anatomo-molecular correlations). The cellular and molecular mechanisms of such "molecular theory" will be reviewed. Third, the geographical distribution of diffuse WHO grade II-III gliomas within populations is heterogeneous, suggesting possible environmental risk factors. We will discuss this "environmental theory". Finally, we will summarize the current knowledge on genetic susceptibility in gliomas ("genetic predisposition theory"). These crucial issues illustrate the close relationships between the pathophysiology of gliomagenesis, the anatomo-functional organization of the brain, and personalized management of DLGG patients.

摘要

弥漫性低级别胶质瘤(DLGG)的起源尚不清楚。除了关于其时间和细胞起源的一些有限数据外,其涉及的机制和风险因素知之甚少。首先,基于 DLGG 发展与这些肿瘤经常侵袭的脑区的功能之间的密切关系,我们提出了一个“功能理论”来解释 DLGG 的起源。其次,参与 DLGG 发生的生物学途径可能因肿瘤位置而异(解剖-分子相关性)。将回顾这种“分子理论”的细胞和分子机制。第三,人群中弥漫性 WHO 分级 II-III 级胶质瘤的地理分布是不均匀的,提示可能存在环境风险因素。我们将讨论这种“环境理论”。最后,我们将总结胶质瘤中遗传易感性的现有知识(“遗传易感性理论”)。这些关键问题说明了胶质瘤发生的病理生理学、大脑的解剖-功能组织以及 DLGG 患者的个体化管理之间的密切关系。

相似文献

1
The etiopathogenesis of diffuse low-grade gliomas.弥漫性低级别胶质瘤的病因发病机制。
Crit Rev Oncol Hematol. 2017 Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Epub 2016 Nov 27.
2
Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.IDH1 突变型弥漫性低级别胶质瘤的细胞和分子特征分析揭示了肿瘤异质性和 EGFR/PDGFRα 激活缺失。
Glia. 2018 Feb;66(2):239-255. doi: 10.1002/glia.23240. Epub 2017 Oct 13.
3
Surgery of insular and paralimbic diffuse low-grade gliomas: technical considerations.岛叶和边缘旁弥漫性低级别胶质瘤的手术:技术要点
J Neurooncol. 2016 Nov;130(2):289-298. doi: 10.1007/s11060-016-2120-2. Epub 2016 May 9.
4
Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.弥漫性低级别胶质瘤次全切除术后的长期预后:一项长达11年随访的连续病例系列研究
Acta Neurochir (Wien). 2016 Jan;158(1):51-8. doi: 10.1007/s00701-015-2621-3. Epub 2015 Nov 3.
5
Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery.识别低级别胶质瘤的临床风险及合适的治疗策略,特别强调手术的作用。
Expert Rev Anticancer Ther. 2017 Aug;17(8):703-716. doi: 10.1080/14737140.2017.1342537. Epub 2017 Jun 28.
6
A new philosophy in surgery for diffuse low-grade glioma (DLGG): oncological and functional outcomes.弥漫性低级别胶质瘤(DLGG)手术的新理念:肿瘤学和功能预后。
Neurochirurgie. 2013 Feb;59(1):2-8. doi: 10.1016/j.neuchi.2012.11.001. Epub 2013 Feb 12.
7
Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data.弥散性低级别胶质瘤的影像学边界外侵犯:基于组织病理学和磁共振成像数据的配准。
J Neurosurg. 2016 Nov;125(5):1155-1166. doi: 10.3171/2015.10.JNS15583. Epub 2016 Feb 26.
8
Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.高级别胶质瘤患者的靶向治疗:过去、现在与未来
Curr Treat Options Oncol. 2016 Aug;17(8):42. doi: 10.1007/s11864-016-0418-0.
9
Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas.弥漫性低级别胶质瘤的临床表现、自然病史及预后
Neurosurg Clin N Am. 2019 Jan;30(1):35-42. doi: 10.1016/j.nec.2018.08.002. Epub 2018 Nov 1.
10
[Update on surgery for diffuse low-grade gliomas: brain mapping, hodotopy and neuroplasticity].[弥漫性低级别胶质瘤手术的最新进展:脑图谱、传导通路定位与神经可塑性]
Bull Acad Natl Med. 2011 Jan;195(1):37-49; discussion 49-51.

引用本文的文献

1
Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma.胶质瘤的解剖分布及预后异质性:枕叶胶质母细胞瘤的独特临床特征
J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05144-4.
2
Neuroplasticity in Diffuse Low-grade Gliomas: Backward Modelling of Brain-tumor Interactions Prior to Diagnosis is Needed to Better Predict Recovery after Treatment.弥漫性低级别胶质瘤中的神经可塑性:需要在诊断前对脑肿瘤相互作用进行逆向建模,以更好地预测治疗后的恢复情况。
Curr Neurol Neurosci Rep. 2025 Jan 9;25(1):15. doi: 10.1007/s11910-024-01402-6.
3
New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction.
脑胶质瘤频率图谱的新见解:从遗传和转录组相关性到生存预测。
Int J Cancer. 2023 Mar 1;152(5):998-1012. doi: 10.1002/ijc.34336. Epub 2022 Nov 24.
4
A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead.低级别胶质瘤患者的个性化纵向策略:预测肿瘤学和神经个体间变异性及其多年来的变化以提前一步思考。
J Pers Med. 2022 Oct 1;12(10):1621. doi: 10.3390/jpm12101621.
5
Preoperative imaging features: Are they useful tools for predicting IDH1 mutation status in gliomas Grades II-IV?术前影像学特征:它们是预测II-IV级胶质瘤中异柠檬酸脱氢酶1(IDH1)突变状态的有用工具吗?
Surg Neurol Int. 2022 Aug 5;13:332. doi: 10.25259/SNI_373_2022. eCollection 2022.
6
Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas.低级别胶质瘤中自噬相关基因特征的预后模型、列线图构建及验证
Front Genet. 2022 Jul 18;13:905751. doi: 10.3389/fgene.2022.905751. eCollection 2022.
7
White Matter Tracts and Diffuse Lower-Grade Gliomas: The Pivotal Role of Myelin Plasticity in the Tumor Pathogenesis, Infiltration Patterns, Functional Consequences and Therapeutic Management.白质纤维束与弥漫性低级别胶质瘤:髓鞘可塑性在肿瘤发病机制、浸润模式、功能后果及治疗管理中的关键作用
Front Oncol. 2022 Mar 2;12:855587. doi: 10.3389/fonc.2022.855587. eCollection 2022.
8
Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas.基于磁共振成像的列线图用于低级别胶质瘤术前肿瘤突变负荷预测的开发与验证
Quant Imaging Med Surg. 2022 Mar;12(3):1684-1697. doi: 10.21037/qims-21-300.
9
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas.METTL21B 是低级别脑胶质瘤的预后生物标志物和潜在治疗靶点。
Aging (Albany NY). 2021 Aug 26;13(16):20661-20683. doi: 10.18632/aging.203454.
10
Association between health insurance status and malignant glioma.健康保险状况与恶性胶质瘤之间的关联。
Neurooncol Pract. 2020 Jun 6;7(5):531-540. doi: 10.1093/nop/npaa030. eCollection 2020 Oct.